Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Total Liabilities (2020 - 2025)

Arcutis Biotherapeutics has reported Total Liabilities over the past 6 years, most recently at $243.5 million for Q4 2025.

  • Quarterly results put Total Liabilities at $243.5 million for Q4 2025, up 27.25% from a year ago — trailing twelve months through Dec 2025 was $243.5 million (up 27.25% YoY), and the annual figure for FY2025 was $243.5 million, up 27.25%.
  • Total Liabilities for Q4 2025 was $243.5 million at Arcutis Biotherapeutics, up from $212.9 million in the prior quarter.
  • Over the last five years, Total Liabilities for ARQT hit a ceiling of $280.7 million in Q3 2024 and a floor of $18.4 million in Q2 2021.
  • Median Total Liabilities over the past 5 years was $225.8 million (2022), compared with a mean of $185.0 million.
  • Biggest five-year swings in Total Liabilities: skyrocketed 891.71% in 2022 and later dropped 24.28% in 2024.
  • Arcutis Biotherapeutics' Total Liabilities stood at $110.5 million in 2021, then surged by 116.97% to $239.7 million in 2022, then rose by 5.43% to $252.7 million in 2023, then decreased by 24.28% to $191.3 million in 2024, then rose by 27.25% to $243.5 million in 2025.
  • The last three reported values for Total Liabilities were $243.5 million (Q4 2025), $212.9 million (Q3 2025), and $213.5 million (Q2 2025) per Business Quant data.